163 related articles for article (PubMed ID: 19790244)
1. Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection.
Petzold A; Groves M; Leis AA; Scaravilli F; Stokic DS
Muscle Nerve; 2010 Jan; 41(1):42-9. PubMed ID: 19790244
[TBL] [Abstract][Full Text] [Related]
2. Glial S100B is elevated in serum across the spectrum of West Nile virus infection.
Leis AA; Stokic DS; Petzold A
Muscle Nerve; 2012 Jun; 45(6):826-30. PubMed ID: 22581535
[TBL] [Abstract][Full Text] [Related]
3. Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome.
Petzold A; Michel P; Stock M; Schluep M
J Stroke Cerebrovasc Dis; 2008; 17(4):196-203. PubMed ID: 18589339
[TBL] [Abstract][Full Text] [Related]
4. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
[TBL] [Abstract][Full Text] [Related]
5. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
6. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
[TBL] [Abstract][Full Text] [Related]
7. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
Trysberg E; Nylen K; Rosengren LE; Tarkowski A
Arthritis Rheum; 2003 Oct; 48(10):2881-7. PubMed ID: 14558094
[TBL] [Abstract][Full Text] [Related]
8. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders.
Constantinescu R; Rosengren L; Johnels B; Zetterberg H; Holmberg B
Parkinsonism Relat Disord; 2010 Feb; 16(2):142-5. PubMed ID: 19647470
[TBL] [Abstract][Full Text] [Related]
9. Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury.
Rejdak K; Kuhle J; Rüegg S; Lindberg RL; Petzold A; Sulejczak D; Papuc E; Rejdak R; Stelmasiak Z; Grieb P
Epilepsia; 2012 May; 53(5):922-7. PubMed ID: 22509781
[TBL] [Abstract][Full Text] [Related]
10. Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease.
Kapoor H; Signs K; Somsel P; Downes FP; Clark PA; Massey JP
J Clin Virol; 2004 Dec; 31(4):289-91. PubMed ID: 15494271
[TBL] [Abstract][Full Text] [Related]
11. Epidemic West Nile virus encephalitis in Tunisia.
Feki I; Marrakchi C; Ben Hmida M; Belahsen F; Ben Jemaa M; Maaloul I; Kanoun F; Ben Hamed S; Mhiri C
Neuroepidemiology; 2005; 24(1-2):1-7. PubMed ID: 15459502
[TBL] [Abstract][Full Text] [Related]
12. West Nile virus immunoglobulin A (WNV IgA) detection in cerebrospinal fluid in relation to WNV IgG and IgM reactivity.
Nixon ML; Prince HE
J Clin Virol; 2006 Nov; 37(3):174-8. PubMed ID: 16939715
[TBL] [Abstract][Full Text] [Related]
13. Detection of West Nile virus in formalin-fixed, paraffin-embedded human tissues by RT-PCR: a useful adjunct to conventional tissue-based diagnostic methods.
Bhatnagar J; Guarner J; Paddock CD; Shieh WJ; Lanciotti RS; Marfin AA; Campbell GL; Zaki SR
J Clin Virol; 2007 Feb; 38(2):106-11. PubMed ID: 17161650
[TBL] [Abstract][Full Text] [Related]
14. Multilevel somatosensory evoked potentials and cerebrospinal proteins: indicators of spinal cord injury in thoracoabdominal aortic aneurysm surgery.
Winnerkvist A; Anderson RE; Hansson LO; Rosengren L; Estrera AE; Huynh TT; Porat EE; Safi HJ
Eur J Cardiothorac Surg; 2007 Apr; 31(4):637-42. PubMed ID: 17306553
[TBL] [Abstract][Full Text] [Related]
15. Neurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitis.
Sellner J; Davies NW; Howard RS; Petzold A
Eur J Neurol; 2014 Jun; 21(6):845-50. PubMed ID: 24684186
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group box-1, promising serological biomarker for the distinction of human WNV disease severity.
Fraisier C; Papa A; Almeras L
Virus Res; 2015 Jan; 195():9-12. PubMed ID: 25197038
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical aftermath of amateur boxing.
Zetterberg H; Hietala MA; Jonsson M; Andreasen N; Styrud E; Karlsson I; Edman A; Popa C; Rasulzada A; Wahlund LO; Mehta PD; Rosengren L; Blennow K; Wallin A
Arch Neurol; 2006 Sep; 63(9):1277-80. PubMed ID: 16966505
[TBL] [Abstract][Full Text] [Related]
18. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features.
Kleinschmidt-DeMasters BK; Marder BA; Levi ME; Laird SP; McNutt JT; Escott EJ; Everson GT; Tyler KL
Arch Neurol; 2004 Aug; 61(8):1210-20. PubMed ID: 15313837
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection.
Li J; Loeb JA; Shy ME; Shah AK; Tselis AC; Kupski WJ; Lewis RA
Ann Neurol; 2003 Jun; 53(6):703-10. PubMed ID: 12783415
[TBL] [Abstract][Full Text] [Related]
20. An ELISA for glial fibrillary acidic protein.
Petzold A; Keir G; Green AJ; Giovannoni G; Thompson EJ
J Immunol Methods; 2004 Apr; 287(1-2):169-77. PubMed ID: 15099765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
